“…Our previous research showed that some of the tested agents based on the core of pyrrolidino-2,5-dione revealed prominent anticonvulsant properties in 'classical' animal models of seizures, i.e., MES, scPTZ, as well as in the 6 Hz model of pharmacoresistant limbic seizures and displayed distinctly better safety profile than clinically relevant anticonvulsant drugs (Kamiński et al, 2015a;Obniska et al, 2015aObniska et al, , 2015bRapacz et al, 2016;Rybka et al, , 2015Rybka et al, , 2014. Moreover, several compounds demonstrated analgesic activity in the formalin model of tonic pain in mice (Obniska et al, , 2015bRapacz et al, 2016).…”